Cabazitaxel is prescribed to treat prostate cancer that has not responded adequately to other cancer treatments. It is administered intravenously once every three weeks and is used in combination with oral prednisone tablets. This medication can help stop cancer cells from growing and multiplying by interfering with certain structures in the cell. Side effects may include anemia and low white blood cells.
Cabazitaxel (Jevtana®) is a chemotherapy medication approved for the treatment of prostate cancer. Specifically, it is approved for use when certain other treatments have failed, and should be used in combination with prednisone.
(Click What Is Cabazitaxel Used For? for more information on this topic, including possible off-label uses.)
Just like any medicine, cabazitaxel can cause side effects. However, not everyone who receives the medication will have problems. In fact, some people tolerate it quite well, although most people will develop side effects.
If reactions do occur, in many cases, they are minor and either require no treatment or are treated easily by you or your healthcare provider. However, as with most chemotherapy medications, serious side effects are quite common.
Common side effects seen with cabazitaxel include but are not limited to:
- Anemia (see Chemotherapy and Anemia)
- Leukopenia (low levels of a certain type of white blood cell called leukocytes)
- Neutropenia (low levels of a certain type of white blood cell called neutrophils).
(Click Side Effects of Cabazitaxel to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)